About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
In this model, we demonstrated that the increased expression of sphingolipids enzyme affects PI3K-AKT signaling axis and its downstream signaling mediators resulting in cancer progression. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_glucose_metabolism",
"label": "Glucose Metabolism",
"units": "native SBML value",
"default": 518000,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_glucose_metabolism",
"description": "Initial Glucose Metabolism. Sets the initial value of bundled SBML symbol `mwcc0d0d1e_f9ca_43ca_a94d_dbf4e0efbc13`."
},
{
"name": "initial_ras",
"label": "Ras",
"units": "native SBML value",
"default": 100000,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_ras",
"description": "Initial Ras. Sets the initial value of bundled SBML symbol `mw338974cb_3199_4092_a3fe_e32b9b3fc4d6`."
},
{
"name": "initial_pi3_k",
"label": "PI3K",
"units": "native SBML value",
"default": 216000,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_pi3_k",
"description": "Initial PI3K. Sets the initial value of bundled SBML symbol `mw1906ffc7_edd7_4567_8b41_84201e788393`."
},
{
"name": "initial_grb2",
"label": "GRB2",
"units": "native SBML value",
"default": 986,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_grb2",
"description": "Initial GRB2. Sets the initial value of bundled SBML symbol `mwe5fc6bf1_e5b9_4f84_b107_5828de7af61b`."
},
{
"name": "initial_sos",
"label": "SOS",
"units": "native SBML value",
"default": 986,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_sos",
"description": "Initial SOS. Sets the initial value of bundled SBML symbol `mw25445311_570d_491b_835f_c395e5a4003a`."
},
{
"name": "initial_irs",
"label": "IRS",
"units": "native SBML value",
"default": 986,
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.initial_irs",
"description": "Initial IRS. Sets the initial value of bundled SBML symbol `mw36987a2d_4042_4802_add1_f8d289da6b4a`."
}
],
"outputs": [
{
"name": "glucose_metabolism",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.glucose_metabolism",
"description": "Glucose Metabolism observable. Maps to SBML symbol `mwcc0d0d1e_f9ca_43ca_a94d_dbf4e0efbc13`."
},
{
"name": "ras",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.ras",
"description": "Ras observable. Maps to SBML symbol `mw338974cb_3199_4092_a3fe_e32b9b3fc4d6`."
},
{
"name": "pi3_k",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.pi3_k",
"description": "PI3K observable. Maps to SBML symbol `mw1906ffc7_edd7_4567_8b41_84201e788393`."
},
{
"name": "grb2",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.grb2",
"description": "GRB2 observable. Maps to SBML symbol `mwe5fc6bf1_e5b9_4f84_b107_5828de7af61b`."
},
{
"name": "sos",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.sos",
"description": "SOS observable. Maps to SBML symbol `mw25445311_570d_491b_835f_c395e5a4003a`."
},
{
"name": "irs",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.irs",
"description": "IRS observable. Maps to SBML symbol `mw36987a2d_4042_4802_add1_f8d289da6b4a`."
},
{
"name": "state",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"metabolism",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Gulhane2022 - Sphingolipid metabolism and PI3K-AKT axis in NSCLC Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model_state"
],
"from": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.state"
},
{
"to": [
"visualisation.oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model_summary"
],
"from": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model_species_labels"
],
"from": "oncology_sbml_gulhane2022_sphingolipid_metabolism_and_pi3k_akt_model2402290001_model.species_labels"
}
],
"package": "gulhane2022-sphingolipid-metabolism-and-pi3k-akt-axis-in-nsclc",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "In this model, we demonstrated that the increased expression of sphingolipids enzyme affects PI3K-AKT signaling axis and its downstream signaling mediators resulting in cancer progression. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagegulhane2022-sphingolipid-metabolism-and-pi3k-akt-axis-in-nsclc
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfulmetabolismoncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisationother